# Tumor Characteristics, Pre-transplant Treatments and Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

> **NCT02995096** · — · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 23124 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **PROCEDURE:** Pre-treatment
- **DRUG:** Sirolimus based immunosuppression

## Key facts

- **NCT ID:** NCT02995096
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2018-10
- **Final completion:** 2019-03
- **Target enrollment:** 23124 (ACTUAL)
- **Last updated:** 2019-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02995096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02995096, "Tumor Characteristics, Pre-transplant Treatments and Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02995096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*